Form 10-Q SCICLONE PHARMACEUTICALS For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Sciclone Pharma (SCLN) Reports Q2 EPS of $0.20
August 9, 2016 4:59 PM EDTSciclone Pharma (NASDAQ: SCLN) reported Q2 EPS of $0.20, versus $0.26 reported last year. Revenue for the quarter came in at $39 million, versus $37.9 million reported last year.
Outlook for 2016
SciClone projects its 2016 revenue to be in the range of $158 million... More

